Danaher Corp (DHR) concluded trading on Wednesday at a closing price of $210.26, with 4.13 million shares of worth about $867.39 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -23.83% during that period and on Wednesday the price saw a loss of about -1.18%. Currently the company’s common shares owned by public are about 719.10M shares, out of which, 647.87M shares are available for trading.
Stock saw a price change of 2.59% in past 5 days and over the past one month there was a price change of 2.80%. Year-to-date (YTD), DHR shares are showing a performance of -8.40% which decreased to -15.69% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $196.80 but also hit the highest price of $281.70 during that period. The average intraday trading volume for Danaher Corp shares is 4.29 million. The stock is currently trading 0.65% above its 20-day simple moving average (SMA20), while that difference is down -4.05% for SMA50 and it goes to -14.61% lower than SMA200.
Danaher Corp (NYSE: DHR) currently have 719.10M outstanding shares and institutions hold larger chunk of about 81.45% of that.
The stock has a current market capitalization of $150.27B and its 3Y-monthly beta is at 0.85. PE ratio of stock for trailing 12 months is 39.76, while it has posted earnings per share of $5.29 in the same period. Its PEG reads 4.77 and has Quick Ratio of 1.05 while making debt-to-equity ratio of 0.35. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for DHR, volatility over the week remained 1.95% while standing at 2.32% over the month.
Stock’s fiscal year EPS is expected to rise by 2.06% while it is estimated to increase by 12.29% in next year. EPS is likely to shrink at an annualized rate of 8.34% for next 5-years, compared to annual growth of 9.03% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Stifel on March 14, 2025 offering a Buy rating for the stock and assigned a target price of $260 to it. On December 23, 2024, Scotiabank Initiated their recommendations, while on December 19, 2024, Guggenheim Initiated their ratings for the stock with a price target of $275. Stock get a Buy rating from BofA Securities on December 13, 2024.
